登录 注册 会员服务 联系我们

Immunotherapy for Non-small Cell Lung Cancer

  • Published:2023 Issue: Volume: Page:1-9
  • ISSN:
  • Container-title:Handbook of Cancer and Immunology
  • language:
  • Short-container-title:

Author:

Minervini Fabrizio,Boschetti Laura,Pardo Esther

Publisher

Springer International Publishing

Reference27 articles.

1. Bar J, Urban D, Ofek E, Ackerstein A, Redinsky I, Golan N, Kamer I, Simansky D, Onn A, Raskin S, Shulimzon T, Peled M, Zeitlin N, Halparin S, Jurkowicz M, Abukhalil R, Perelman M, Ben-Nun A (2019) Neoadjuvant pembrolizumab (Pembro) for early stage non-small cell lung cancer (NSCLC): updated report of a phase I study, MK3475-223. J Clin Oncol 37(15_suppl):8534

2. Betticher DC, Hsu Schmitz SF, Tötsch M, Hansen E, Joss C, von Briel C, Schmid RA, Pless M, Habicht J, Roth AD, Spiliopoulos A, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Ris HB (2003) Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21(9):1752–1759. https://doi.org/10.1200/JCO.2003.11.040. PMID: 12721251

3. Bott MJ, Yang SC, Park BJ, Adusumilli PS, Rusch VW, Isbell JM, Downey RJ, Brahmer JR, Battafarano R, Bush E, Chaft J, Forde PM, Jones DR, Broderick SR (2019) Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 158(1):269–276. https://doi.org/10.1016/j.jtcvs.2018.11.124. Epub 2018 Dec 13. PMID: 30718052; PMCID: PM-C6653596

4. Burdett S, Pignon JP, Tierney J et al (2015) Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Cochrane Database Syst Rev (3):CD011430. https://doi.org/10.1002/14651858.CD011430

5. Cascone T, William WN, Weissferdt A et al (2021) Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med 27:504–514

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A brief history of lung cancer in Canada: Care, contributions and challenges;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-09-03
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3